US Stock MarketDetailed Quotes

VANI Vivani Medical

Watchlist

1.440
-0.010-0.69%

Close Nov 29 13:00 ET

1.450
+0.010+0.69%

Post 16:40 ET

85.30MMarket Cap-3348P/E (TTM)

Vivani Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

26.50%-5.66M

13.50%-4.8M

35.23%-4.51M

-26.15%-23.7M

33.10%-3.48M

-10.68%-7.7M

-60.92%-5.55M

-119.33%-6.97M

-71.56%-18.79M

-75.84%-5.2M

Net income from continuing operations

10.93%-6.04M

17.93%-5.36M

4.42%-6.04M

-84.69%-25.65M

17.27%-6.03M

-576.60%-6.78M

-59.02%-6.53M

-61.01%-6.32M

-8.74%-13.89M

-101.22%-7.28M

Operating gains losses

----

--121K

----

Depreciation and amortization

57.75%112K

25.00%100K

-8.33%99K

-6.30%357K

-10.91%98K

-29.70%71K

-8.05%80K

30.12%108K

10.43%381K

32.53%110K

Other non cash items

-91.30%61K

-61.58%73K

232.26%82K

113.08%904K

227.12%75K

110.15%701K

603.70%190K

-329.63%-62K

-1,002.55%-6.91M

-326.92%-59K

Change In working capital

87.97%-265K

-119.23%-35K

193.41%993K

-482.54%-1.29M

-3.66%1.79M

-12.05%-2.2M

23.81%182K

-456.71%-1.06M

-22.48%338K

1,488.89%1.86M

-Change in prepaid assets

78.72%-429K

140.11%448K

463.40%556K

155.46%264K

1,023.42%3.55M

-229.95%-2.02M

-830.83%-1.12M

-150.82%-153K

-566.67%-476K

364.71%316K

-Change in payables and accrued expense

187.70%164K

-137.18%-483K

148.02%437K

-291.28%-1.56M

-214.00%-1.76M

86.20%-187K

386.52%1.3M

-353.48%-910K

143.71%814K

3,048.98%1.54M

Cash from discontinued investing activities

Operating cash flow

26.50%-5.66M

13.50%-4.8M

35.23%-4.51M

-26.15%-23.7M

33.10%-3.48M

-10.68%-7.7M

-60.92%-5.55M

-119.33%-6.97M

-71.56%-18.79M

-75.84%-5.2M

Investing cash flow

Cash flow from continuing investing activities

34.92%-41K

15.91%-37K

-391.89%-182K

-162.43%-887K

-1,712.20%-743K

65.19%-63K

48.84%-44K

-23.33%-37K

40.91%-338K

83.98%-41K

Net PPE purchase and sale

34.92%-41K

15.91%-37K

-391.89%-182K

-162.43%-887K

-734.83%-743K

52.63%-63K

48.84%-44K

-23.33%-37K

40.91%-338K

65.23%-89K

Cash from discontinued investing activities

Investing cash flow

34.92%-41K

15.91%-37K

-391.89%-182K

-162.43%-887K

-1,712.20%-743K

65.19%-63K

48.84%-44K

-23.33%-37K

40.91%-338K

83.98%-41K

Financing cash flow

Cash flow from continuing financing activities

314.56%427K

1,457.14%109K

13.69M

-99.79%133K

23K

-99.81%103K

-41.67%7K

445.52%63.39M

Net common stock issuance

--48K

--112K

--13.69M

731.25%133K

--133K

--0

-99.86%16K

----

Proceeds from stock option exercised by employees

--0

-142.86%-3K

--3K

----

--103K

--7K

--0

----

Net other financing activities

----

--63.37M

--0

Cash from discontinued financing activities

Financing cash flow

314.56%427K

1,457.14%109K

--13.69M

-99.79%133K

--23K

-99.81%103K

-41.67%7K

--0

445.52%63.39M

--0

Net cash flow

Beginning cash position

-22.44%26.26M

-21.43%30.99M

-52.65%21.99M

2,032.32%46.44M

-49.33%26.19M

881.22%33.85M

465.60%39.44M

2,032.32%46.44M

4.66%2.18M

4,294.90%51.68M

Current changes in cash

31.15%-5.28M

15.36%-4.73M

228.46%9M

-155.24%-24.45M

19.89%-4.2M

-115.88%-7.66M

-58.59%-5.59M

-246.05%-7M

45,534.02%44.27M

-623.35%-5.24M

Effect of exchange rate changes

166.67%2K

--0

---2K

400.00%3K

200.00%6K

0.00%-3K

--0

---1K

--2K

End cash Position

-19.87%20.98M

-22.44%26.26M

-21.43%30.99M

-52.65%21.99M

-49.33%26.19M

881.22%33.85M

465.60%39.44M

2,032.32%46.44M

Free cash flow

26.57%-5.7M

13.51%-4.84M

32.97%-4.69M

-28.55%-24.59M

19.45%-4.22M

-8.75%-7.77M

-58.25%-5.59M

-118.43%-7M

-65.97%-19.13M

-63.11%-5.24M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	26.50%-5.66M	13.50%-4.8M	35.23%-4.51M	-26.15%-23.7M	33.10%-3.48M	-10.68%-7.7M	-60.92%-5.55M	-119.33%-6.97M	-71.56%-18.79M	-75.84%-5.2M
Net income from continuing operations	10.93%-6.04M	17.93%-5.36M	4.42%-6.04M	-84.69%-25.65M	17.27%-6.03M	-576.60%-6.78M	-59.02%-6.53M	-61.01%-6.32M	-8.74%-13.89M	-101.22%-7.28M
Operating gains losses	----	----	----	--121K	----	----	----	----	----	----
Depreciation and amortization	57.75%112K	25.00%100K	-8.33%99K	-6.30%357K	-10.91%98K	-29.70%71K	-8.05%80K	30.12%108K	10.43%381K	32.53%110K
Other non cash items	-91.30%61K	-61.58%73K	232.26%82K	113.08%904K	227.12%75K	110.15%701K	603.70%190K	-329.63%-62K	-1,002.55%-6.91M	-326.92%-59K
Change In working capital	87.97%-265K	-119.23%-35K	193.41%993K	-482.54%-1.29M	-3.66%1.79M	-12.05%-2.2M	23.81%182K	-456.71%-1.06M	-22.48%338K	1,488.89%1.86M
-Change in prepaid assets	78.72%-429K	140.11%448K	463.40%556K	155.46%264K	1,023.42%3.55M	-229.95%-2.02M	-830.83%-1.12M	-150.82%-153K	-566.67%-476K	364.71%316K
-Change in payables and accrued expense	187.70%164K	-137.18%-483K	148.02%437K	-291.28%-1.56M	-214.00%-1.76M	86.20%-187K	386.52%1.3M	-353.48%-910K	143.71%814K	3,048.98%1.54M
Cash from discontinued investing activities
Operating cash flow	26.50%-5.66M	13.50%-4.8M	35.23%-4.51M	-26.15%-23.7M	33.10%-3.48M	-10.68%-7.7M	-60.92%-5.55M	-119.33%-6.97M	-71.56%-18.79M	-75.84%-5.2M
Investing cash flow
Cash flow from continuing investing activities	34.92%-41K	15.91%-37K	-391.89%-182K	-162.43%-887K	-1,712.20%-743K	65.19%-63K	48.84%-44K	-23.33%-37K	40.91%-338K	83.98%-41K
Net PPE purchase and sale	34.92%-41K	15.91%-37K	-391.89%-182K	-162.43%-887K	-734.83%-743K	52.63%-63K	48.84%-44K	-23.33%-37K	40.91%-338K	65.23%-89K
Cash from discontinued investing activities
Investing cash flow	34.92%-41K	15.91%-37K	-391.89%-182K	-162.43%-887K	-1,712.20%-743K	65.19%-63K	48.84%-44K	-23.33%-37K	40.91%-338K	83.98%-41K
Financing cash flow
Cash flow from continuing financing activities	314.56%427K	1,457.14%109K	13.69M	-99.79%133K	23K	-99.81%103K	-41.67%7K	0	445.52%63.39M	0
Net common stock issuance	--48K	--112K	--13.69M	731.25%133K	--133K	--0	--0	--0	-99.86%16K	----
Proceeds from stock option exercised by employees	--0	-142.86%-3K	--3K	----	----	--103K	--7K	--0	----	----
Net other financing activities	----	----	----	----	----	----	----	----	--63.37M	--0
Cash from discontinued financing activities
Financing cash flow	314.56%427K	1,457.14%109K	--13.69M	-99.79%133K	--23K	-99.81%103K	-41.67%7K	--0	445.52%63.39M	--0
Net cash flow
Beginning cash position	-22.44%26.26M	-21.43%30.99M	-52.65%21.99M	2,032.32%46.44M	-49.33%26.19M	881.22%33.85M	465.60%39.44M	2,032.32%46.44M	4.66%2.18M	4,294.90%51.68M
Current changes in cash	31.15%-5.28M	15.36%-4.73M	228.46%9M	-155.24%-24.45M	19.89%-4.2M	-115.88%-7.66M	-58.59%-5.59M	-246.05%-7M	45,534.02%44.27M	-623.35%-5.24M
Effect of exchange rate changes	166.67%2K	--0	---2K	400.00%3K	200.00%6K	0.00%-3K	--0	--0	---1K	--2K
End cash Position	-19.87%20.98M	-22.44%26.26M	-21.43%30.99M	-52.65%21.99M	-52.65%21.99M	-49.33%26.19M	881.22%33.85M	465.60%39.44M	2,032.32%46.44M	2,032.32%46.44M
Free cash flow	26.57%-5.7M	13.51%-4.84M	32.97%-4.69M	-28.55%-24.59M	19.45%-4.22M	-8.75%-7.77M	-58.25%-5.59M	-118.43%-7M	-65.97%-19.13M	-63.11%-5.24M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data